# Safety and Efficacy Study of Posaconazole vs. Fluconazole for Prevention of Invasive Fungal Infection (P05387 AM1)(COMPLETED)

> **NCT00811928** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 252 (actual)

## Conditions studied

- Leukopenia

## Interventions

- **DRUG:** Posaconazole
- **DRUG:** Fluconazole

## Key facts

- **NCT ID:** NCT00811928
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 252 (ACTUAL)
- **Last updated:** 2017-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00811928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00811928, "Safety and Efficacy Study of Posaconazole vs. Fluconazole for Prevention of Invasive Fungal Infection (P05387 AM1)(COMPLETED)". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00811928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*